NCT07357961Not yet recruiting
The Effectiveness of a Theory-driven Behavioral Change Intervention on Sedentary Behavior in Individuals With Coronary Heart Disease: A Randomised Controlled Trial
Source: ClinicalTrials.gov · Last updated 23 Apr 2026
Brief summary (registry, in English)
The objective of this randomised controlled trial is to examine the effectiveness of a theory-driven behavioural change intervention on total sedentary time (primary outcomes), moderate-to-vigorous physical activity time, intention of behavioural change, future time perception, behavioural prepotency, self-regulation capacity, and exercise capacity in individuals with coronary heart disease. Hypotheses: Compared to the participants in the control group, participants in the intervention group will demonstrate: 1. Significantly less total sedentary time 2. Significantly improved MVPA time, 3. Significantly better intention of behavioural change, 4. Significantly higher level of behavioural prepotency, 5. Significantly enhanced self-regulation capacity, and 6. Significantly greater future time perception 7. Significantly better exercise capacity at the immediate post-intervention (T1), the 1-month post-intervention (T2), and the 6-month post-intervention (T3). Participants will: Participants in the intervention group will participate in a theory-driven behavioural change intervention over three months, comprising four individual face-to-face sessions (45 minutes each) and four individual telephone sessions (20 minutes each), along with the usual care. Participants in the attention control group will continue to have the usual care, which includes regular follow-up at the cardiac clinic. Education sessions, consisting of information about healthy lifestyles, except physical activity and sedentary behaviour, with the same schedule as the intervention group, will be provided to account for potential attention effects from contacts.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 232 (estimated)
- First submitted
- 14 Jan 2026
- Start date
- 13 Apr 2026
- Primary completion date
- 31 Oct 2026
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Coronary artery disease
- NCT number
- NCT07357961
What you commit to
- Study type: Interventional
- Planned participants: 232
- From 13 Apr 2026 to the primary completion date, 31 Oct 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Doctor-diagnosed psychiatric illness
Other
- Cannot perform brisk walking exercise
- Unable to perform PA independently
- Cognitive impairments, as indicated by an abbreviated mental test score of less than 7
- Currently enrolled in another clinical trial focusing on limiting SB with/without enhancing PA
Who the study is looking for
- Adult 18 years old and above
- Diagnosed with coronary heart disease within one year
- Engaged in MVPA less than 150 minutes per week and a minimum of 8 hours total sedentary time per day, both assessed using the Global Physical Activity Questionnaire
- Able to communicate in Cantonese
- Obtained medical clearance for physical activity (no medical contraindications to exercise, including walking)
- Being able to understand and give informed consent
- Having telephone access, text messaging services or WhatsApp
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.